{
    "2021-01-08": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Low Forward Price-Earnings Ratio Stock Picks",
                "features": {
                    "keywords": [
                        "Price-Earnings",
                        "Ratio",
                        "Stock",
                        "Picks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Pharma Stock Roundup: ABBV's Positive Skyrizi Data, AZN, PFE, RHHBY's FDA Updates",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "ABBV",
                        "Skyrizi",
                        "Positive",
                        "Data",
                        "AZN",
                        "PFE",
                        "RHHBY",
                        "FDA",
                        "Updates"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie's (ABBV) Skyrizi Succeeds in Crohn's Disease Studies",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "ABBV",
                        "Skyrizi",
                        "Succeeds",
                        "Crohn's",
                        "Disease",
                        "Studies"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}